Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride before open prostatectomy to reduce perioperative blood loss
IRCT20260121068634N3Phase 4Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dutasteride in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood hemoglobin, Hematocrit and 1 more. Started Oct 2026; status: recruiting.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on IRCT20260121068634N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260121068634N3.